Key facts
- This page summarizes Boekhorst Paul Francis Olivier Te's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 Jun 2026, 08:33.
Boekhorst Paul Francis Olivier Te - 18 Jun 2026 Form 4 Insider Report for IMMUCELL CORP /DE/ (ICCC)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- ICCC
- Reported as of
- 18 Jun 2026
- Net transaction value
- +$75,960
- SEC form
- 4
- Accepted by SEC
- 22 Jun 2026, 08:33:34 UTC
- Prior SEC filing
- 23 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Timothy C. Fiori Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Boekhorst Paul Francis Olivier Te filed Form 4 for IMMUCELL CORP /DE/ (ICCC) on 22 Jun 2026.
Change
- Previous filing in this sequence was filed on 23 Mar 2026.
- Current net transaction value: +$75,960.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002095704
Primary reporting owner
te Boekhorst Paul Francis Olivier
- Relationship
- President and CEO, Director
- Address
- C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND
- Signature
- /s/ Timothy C. Fiori Attorney-in-Fact
- Signature date
- 22 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ICCC
transaction
Common Stock, par value $.01 per share
Purchase
- Transaction value
- $75,960
- Shares
- +8,000
- Change %
- +82%
- Price
- $9.50
- Shares after
- 17,785
- Date
- 18 Jun 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.